Skip to main content
Equibles

BALAXI · BALAXI PHARMACEUTICALS LIMITED · Financials

Use BALAXI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BALAXI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
23.44 INR -0.40 (-1.68%) At close · Nov 13
Rebalance outlook locked
Market Cap
1.29B INR
Shares
55.21M
Volume · Nov 13 14.07K Avg daily vol (3M) 35.8K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
2.7B -7.7%
FY2026 Revenue FY2020–FY2026
Net Income
14.17M -94.3%
FY2026 Net Income FY2020–FY2026
Operating Cash Flow
-45M +87.1%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
INR 3.05B 2.7B 2.93B 2.41B 3.36B 2.79B 2.31B 456.32M
INR 34.76M 21.53M 18.95M 20.98M 17.52M 5.12M 2.98M 75K
INR 35.94M 39.04M 29.35M 16.77M 5M 1.42M 131K 0
INR 71.17M 52.93M 286.7M 20.15M 569.22M 545.23M 443.29M 88.74M
INR 37.52M 38.76M 35.99M 44.02M 109.6M 68.65M 61.92M 27.7M
INR 20.68M 14.17M 250.7M 0 0 0 372.34M 61.04M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 4.98M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.